Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Operating Leases (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Operating Leases for 3 consecutive years, with $30.0 million as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 28.74% to $30.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.0 million through Dec 2025, up 28.74% year-over-year, with the annual reading at $30.0 million for FY2025, 28.74% up from the prior year.
  • Operating Leases hit $30.0 million in Q4 2025 for Guardian Pharmacy Services, up from $27.4 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $30.0 million in Q4 2025 to a low of $21.8 million in Q1 2025.
  • Historically, Operating Leases has averaged $25.1 million across 3 years, with a median of $23.8 million in 2024.
  • Biggest five-year swings in Operating Leases: grew 2.17% in 2024 and later increased 28.74% in 2025.
  • Year by year, Operating Leases stood at $22.8 million in 2023, then increased by 2.17% to $23.3 million in 2024, then increased by 28.74% to $30.0 million in 2025.
  • Business Quant data shows Operating Leases for GRDN at $30.0 million in Q4 2025, $27.4 million in Q3 2025, and $26.5 million in Q2 2025.